Медицинская иммунология (Jan 2025)

Influenza vaccine is able to induce post-infection antibodies to SARS-CoV-2 in medical staff

  • M. P. Kostinov,
  • N. Yu. Nastaeva,
  • N. F. Nikityuk,
  • N. K. Akhmatova,
  • M. I. Albahansa,
  • S. V. Yushkova,
  • N. P. Andreeva,
  • A. M. Kostinova,
  • A. V. Linok,
  • M. N. Loktionova,
  • I. A. Khrapunova

DOI
https://doi.org/10.15789/1563-0625-IVI-2982
Journal volume & issue
Vol. 27, no. 1
pp. 169 – 178

Abstract

Read online

Influenza vaccination contributes to the favorable course and outcome of COVID-19. The aim of our study was to study the effect of influenza and pneumococcal vaccines on the level of IgG antibodies (AT) to SARS-CoV-2 among medical personnel at the beginning of the COVID-19 pandemic. We present the data on assessment of specific immune response to the influenza virus and SARS-CoV-2 in 266 medical workers 6 months after immunization against influenza and/or pneumococcal infection (without vaccinations against COVID-19) over the 2020-2021, by comparing the results with respective characteristic in 281 employees with no history of vaccinations is presented.We have found that the proportion of medical workers with a protective (≥ 1:40) antibody levels to influenza virus 6 months after vaccination in groups of participants reaches a protective (≥ 70%) value only in persons who received a monovaccine against pneumococcal infection (78.6%) as compared with persons vaccinated with a monovaccine against influenza (61.7%) (p < 0.001), as well as with a group of workers immunized against influenza in combination with the S. pneumoniae vaccine (68.9%) (p < 0.01). Hence, the pneumococcal vaccine is able to induce the synthesis of IgG-AT to influenza virus reaching protective values.An analysis of the group with seropositivity to influenza virus (IgG-AT ≥ 1:10) and their comparisons with persons seroprevalent to COVID-19 showed that the proportion of seropositive individuals among medical staff vaccinated against seasonal influenza after 6 months (indicating a probable asymptomatic form of COVID-19) is increased. It comprised 65.4% (p = 0.026) in the group vaccinated with mono-flu, and 64.5% (p = 0.04) in the group vaccinated with combined influenza and pneumococcus, being higher than among the non-immunized workers (48.8%).In summary, the results of our study show that influenza vaccination acts as an inducer of humoral immunity not only to the influenza virus, but also to the recently transmitted SARS-CoV-2 infection.

Keywords